BlackRock Health Sciences Trust is a closed-ended equity mutual fund that invests primarily in the U.S. public equity markets, focusing on companies in the health sciences sector. Its customers include individual and institutional investors seeking exposure to health-related equities. Revenue is generated through management fees and performance fees from the fund's investments. The fund targets companies involved in medical, dental, optical, pharmaceutical, or biotechnology products and services, with a significant portion of its strategy involving equity derivatives and option writing. Factors supporting endurance include the growing demand for healthcare investments, while market volatility and regulatory changes could pose risks.
—
BlackRock Health Sciences Trust is a closed-ended equity mutual fund that invests primarily in the U.S. public equity markets, focusing on companies in the health sciences sector. Its customers include individual and institutional investors seeking exposure to health-related equities. Revenue is generated through management fees and performance fees from the fund's investments. The fund targets companies involved in medical, dental, optical, pharmaceutical, or biotechnology products and services, with a significant portion of its strategy involving equity derivatives and option writing. Factors supporting endurance include the growing demand for healthcare investments, while market volatility and regulatory changes could pose risks.
—
Daily adjusted close
BlackRock Health Sciences Trust is a closed-ended equity mutual fund that invests primarily in the U.S. public equity markets, focusing on companies in the health sciences sector. Its customers include individual and institutional investors seeking exposure to health-related equities. Revenue is generated through management fees and performance fees from the fund's investments. The fund targets companies involved in medical, dental, optical, pharmaceutical, or biotechnology products and services, with a significant portion of its strategy involving equity derivatives and option writing. Factors supporting endurance include the growing demand for healthcare investments, while market volatility and regulatory changes could pose risks.